The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index; 31 of the 64 sources its claims cite were checked for support.
Tet-On Systems For Doxycycline-inducible Gene Expression
Open accessAbstract
The tetracycline-controlled Tet-Off and Tet-On gene expression systems are used to regulate the activity of genes in eukaryotic cells in diverse settings, varying from basic biological research to biotechnology and gene therapy applications. These systems are based on regulatory elements that control the activity of the tetracycline-resistance operon in bacteria. The Tet-Off system allows silencing of gene expression by administration of tetracycline (Tc) or tetracycline-derivatives like doxycycline (dox), whereas the Tet-On system allows activation of gene expression by dox. Since the initial design and construction of the original Tet-system, these bacterium-derived systems have been significantly improved for their function in eukaryotic cells. We here review how a dox-controlled HIV-1 variant was designed and used to greatly improve the activity and dox-sensitivity of the rtTA transcriptional activator component of the Tet-On system. These optimized rtTA variants require less dox for activation, which will reduce side effects and allow gene control in tissues where a relatively low dox level can be reached, such as the brain.
Overview
CoChat Summary
TL;DR
This review describes how a doxycycline-controlled HIV-1 variant was used to evolve and improve the rtTA component of the Tet-On system, yielding rtTA variants with greater activity and dox sensitivity. It compares optimized variants (M2, V10, V16) and discusses when each is preferable in vitro and in vivo.
Key findings
- Viral evolution of HIV-rtTA selected tetO-LTR deletions (6 of 8 tetO elements deleted, plus a 14–15 nt spacer deletion) and rtTA mutations including F86Y; F86Y increased transcriptional activity and dox sensitivity without affecting background activity, whereas A209T had no effect.
- rtTA3 (S12G+F86Y+A209T) was 5-fold more active at high dox and required 25-fold less dox than rtTA2S-S2; V16 was 7-fold more active at high dox and 100-fold more sensitive than rtTA2S-S2, with no activity without dox in integrated pTet-reporter assays.
- In transient transfection, V16 had highest dox-induced activity but low detectable background; V10 had no background and superior fold-induction, making V10 optimal for most transient/episomal applications, while V16 is preferred when high activity at low dox is needed.
- In stably transduced cells, V16 showed highest dox-induced activity, fold-induction, and reactivation after dox withdrawal; V16 outperformed M2 for AAV-delivered GDNF in rat brain at clinically-approved sub-antimicrobial dox doses.
Methods
- Narrative review of Tet-Off/Tet-On systems, focusing on optimization of rtTA via a dox-controlled HIV-1 variant (HIV-rtTA) and comparison of rtTA variants.
- Data/sample: synthesis of referenced in vitro, ex vivo, animal, and clinical/preclinical studies; includes comparison of M2, V10, and V16 in transiently transfected and lentivirally transduced cells.
- Main analysis: qualitative synthesis and comparison of dox sensitivity, activity, background, fold-induction, and in vivo applicability; no new primary experimental methods are reported for the review itself.
Limitations
- Stated: direct comparison of new Tet-On systems was limited to in vitro cell culture; optimal rtTA for complex in vivo situations is unknown and may depend on cell/tissue type.
- Stated: in vivo use can be complicated by immune responses against rtTA in rodents and non-human primates, and toxic side effects of tTA/rtTA in transgenic mice; more dox-sensitive rtTA like V16 may show prolonged activity after dox withdrawal.
- Stated: whether S12G and V9I DBD mutations affect rtTA interaction with cellular promoter regions and cellular gene expression remains to be determined. Evident: as a review, it relies on prior studies and includes some unpublished data, so conclusions about variant superiority are context-dependent.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


![Fig. (3) The dox-dependent HIV-rtTA virus. (A) Transcription of wild-type HIV-1 is activated by the binding of the viral Tat protein to the TAR hairpin structure that is present at the 5’ end of nascent RNA transcripts. This Tat-TAR axis thus controls viral gene expression and replication. (B) In HIV-rtTA, Tat and TAR are inactivated by mutation and functionally replaced by the rtTA-tetO components of the Tet-On system, by insertion of the rtTA gene at the site of the nef gene and insertion of tetO sequences in the LTR-promoter region. Transcription of this HIV-1 variant is activated by the binding of rtTA to the tetO-LTR promoter. Because rtTA binds the tetO sites exclusively in the presence of dox, HIV-rtTA does not replicate in the absence of this effector. (C) Dox-controlled replication of HIV-rtTA strains with the original rtTA-2S-S2 gene (left panel) and the F86Y-mutated variant (right panel) in SupT1 T-cells at different dox-concentrations. Virus replication is monitored by measuring the viral capsid protein (CA-p24) in the culture supernatant. Reproduced from [67] (© 2004, the American Society for Biochemistry and Molecular Biology).](https://figures.cochat.ai/paper-figures/d329ffbf491b44c680e3a30aa39250ad/tet-on-systems-for-doxycycline-inducible-gene-expression-figure-3.jpg)
![Fig. (4) Optimization of the Tet-On system through virus evolution. (A) Amino acid substitutions observed in rtTA-2S-S2 (wild-type) upon long-term culturing of HIV-rtTA in human SupT1 T-cells. (B) The transcriptional activity (at 1000 ng/ml dox) and dox-sensitivity of the wild-type, naturally evolved (V1-V10) and constructed (V11-V18) rtTA variants was measured in HeLa X1/6 cells that contain chromosomally integrated copies of the Ptet-luciferase reporter construct. The wild-type rtTA activity at 1000 ng/ml dox was set at 100%. The activity measured at different dox concentrations was used to calculate the dox concentration that each rtTA variant needs to reach an activity comparable to that of the wild-type rtTA at 1000 ng/ml dox. These concentrations are indicated between brackets in the right panel (nd, not determined), and were used to calculate the dox-sensitivity for each rtTA variant (dox-sensitivity of wild-type rtTA set at 1). *, V1-V18 carry the F86Y and A209T mutations in addition to the shown mutations. Reproduced from [69] (© 2006, Zhou et al.).](https://figures.cochat.ai/paper-figures/4cd2258762e040d09f2c52447cab797a/tet-on-systems-for-doxycycline-inducible-gene-expression-figure-4.jpg)
![Fig. (5) Comparison of rtTA variants in transiently transfected and stably transduced cells. (A-C) Different human cell lines (HeLa cervix carcinoma and HEK293 embryonal kidney cells) were transfected with low and high amounts of CMV enhancer/promoter-driven PCMV-rtTA (either rtTA2S-M2 [M2], rtTA-V10 or rtTA-V16) and dox-rtTA activated Ptet-luciferase constructs (constructs shown in A), and cultured in the presence of 0 to 1000 ng/ml dox. (B) The luciferase level measured 2 days after transfection reflects the rtTA activity. The activity of M2 at 1000 ng/ml dox was set at 100%. The average of the values obtained for different experimental conditions (different cells and different amounts of DNA) [70] is shown to illustrate the differences between the rtTA variants (no, transfection of cells with the empty vector instead of the rtTA plasmid). The original data for each cell line and amount of DNA are presented in [70]. (C) Fold induction levels, calculated as the ratio between the rtTA activity at the indicated dox concentration and the activity in the absence of dox (0 ng/ml). (D-H) Different human cell lines (SupT1, HeLa, HepG2 hepatocellular carcinoma and SJNB-8 neuroblastoma cells) were transduced with a lentiviral vector containing Ptet-d2EGFP and PCMV-rtTA (M2, V10 or V16) cassettes (construct shown in D). Cells were cultured with dox for 3 days. GFP-positive (GFP+) cells were sorted and cultured without dox for 6 days to switch off GFP expression. The isolated transduced cells were subsequently cultured with different dox concentrations for 3 days, after which the intracellular GFP level was analyzed. (E) The mean fluorescent intensity (MFI) of the total cell population reflects the rtTA activity. The activity of M2 at 1000 ng/ml dox was set at 100%. The average of the values obtained with the different cells (original data published in [70]) is shown to illustrate the differences between the rtTA variants. (F) Fold induction levels, calculated as the ratio between the MFI at the indicated dox concentration and the MFI in the absence of dox (0 ng/ml). (G) The average percentage of GFP+ cells measured for the SupT1, HeLa and SJNB-8 cells that express GFP predominantly in a threshold mode (i.e. increasing the dox concentration activated GFP expression in more cells, rather than that it increased the fluorescence intensity of the GFP+ cells [89]; original data published in [70]). (H) The percentage of GFP+ cells measured for HepG2 cells that express GFP predominantly in a graded mode (i.e. increasing the dox concentration predominantly increased the fluorescence intensity of the GFP+ cells [89]).](https://figures.cochat.ai/paper-figures/676598994a284d2fadd8709630608bfd/tet-on-systems-for-doxycycline-inducible-gene-expression-figure-5.jpg)

Verification
Claims the paper makes
22 Valid · 0 Not valid · 15 Not checked · 21 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The Tet-Off and Tet-On systems are based on the Tet repressor protein (TetR) and tet operator (tetO) DNA elements that control the Tn10-encoded tetracycline resistance operon of Escherichia coli.”
- Also stated in: § The Bacterial Tet Operon · plain
“In the Tn10-encoded Tet operon, the tetA and tetR genes are oriented in opposite direction and their expression is regulated at the transcription level by a shared regulatory region (Fig. 1A).”
§ Tet-On Systems For Doxycycline-inducible Gene Expression > Introduction
What the sources say
- Partly supportedcites [7] Bertram R. Hillen W. The application of Tet repressor in prokaryotic gene regulation and expression. Microb. Biotechnol. 2008 1 1 2 16 21261817 PMC3864427 sourceExperimental — accuracy not yet measured
The ‘Origin of tet regulation’ section (page unavailable) describes TetR binding tetO to regulate the Tn10 tetracycline-resistance genes, supporting the claim about the underlying components. Our copy does not establish that the specifically named Tet-Off and Tet-On systems are based on those components. (LLM, conf=0.82)
- Partly supportedcites [8] Meier I. Wray L.V. Hillen W. Differential regulation of the Tn10-encoded tetracycline resistance genes tetA and tetR by the tandem tet operators O1 and O2. EMBO J. 1988 7 2 567 572 2835235 PMC454355 sourceExperimental — accuracy not yet measured
The Abstract reports that Tet repressor binds the Tn10 tet operators and regulates expression of the tetracycline-resistance gene tetA. Our copy does not discuss Tet-Off or Tet-On systems or establish that they are based on these elements. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § The Bacterial Tet Operon · plain
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The pTet promoter has been optimized through systematic modification, which resulted in novel promoter configurations that minimized intrinsic background activity while maintaining high induced expression [13, 14].”
§ Tet-On Systems For Doxycycline-inducible Gene Expression > Introduction > Improvements of the TET-On system
What the sources say
- Supportedcites [13] Loew R. Heinz N. Hampf M. Bujard H. Gossen M. Improved Tet-responsive promoters with minimized background expression. BMC Biotechnol. 2010 10 81 10.1186/1472-6750-10-81 21106052 PMC3002914 source
The Background describes stepwise modifications of Ptet-1 to create novel promoter variants with low intrinsic background activity and high induced expression. It reports that several variants had lower off-state background than Ptet-1 and Ptet-14 while retaining high activation potential. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [14] Agha-Mohammadi S. OMalley M. Etemad A. Wang Z. Xiao X. Lotze M.T. Second-generation tetracycline-regulatable promoter: repositioned tet operator elements optimize transactivator synergy while shorter minimal promoter offers tight basal leakiness. J. Gene Med. 2004 6 7 817 828 10.1002/jgm.566 15241789 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“A second round of mutagenesis and screening in S. cerevisiae yielded an additional DBD mutation (S12G) that increased the activity of rtTA-S2, in particular at low dox concentrations.”
§ Tet-On Systems For Doxycycline-inducible Gene Expression > Introduction > Improvements of the TET-On system
What the sources say
- Supportedcites [15] Urlinger S. Baron U. Thellmann M. Hasan M.T. Bujard H. Hillen W. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc. Natl. Acad. Sci. USA 2000 97 14 7963 7968 10.1073/pnas.130192197 10859354 PMC16653 source
The Results (page not provided) say a second round of mutagenesis and screening in S. cerevisiae identified a serine-to-glycine change at position 12 in the DNA reading head. The screened variant was rtTA-19/56, derived from rtTA-S2; restoring rtTA-S2’s other two mutations produced rtTA-M2. The Discussion (page not provided) reports that rtTA2S-M2 is fully induced at about a tenfold lower Dox concentration than rtTA2S-S2. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“We used the Tet-On system to generate an HIV-1 variant that replicates exclusively in the presence of dox [42].”
§ Tet-On Systems For Doxycycline-inducible Gene Expression > A dox-controlled HIV-1 variant as a tool to improve the TET-On system
What the sources say
- Supportedcites [42] Verhoef K. Marzio G. Hillen W. Bujard H. Berkhout B. Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat. J. Virol. 2001 75 2 979 987 10.1128/JVI.75.2.979-987.2001 11134311 PMC113994 source
The Abstract describes HIV-rtTA variants made by replacing the Tat-TAR system with the Tet system and says they replicate exclusively upon addition of doxycycline. The Results section reports no replication without dox, supporting the claim's “exclusively” qualifier. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Recent studies successfully applied V16 to control transgene expression in mice [85, 86] and non-human primates [62, 87].”
§ Tet-On Systems For Doxycycline-inducible Gene Expression > Optimal TET-On system for in vivo applications
What the sources say
- Supportedcites [85] Sooksawate T. Isa K. Matsui R. Kato S. Kinoshita M. Kobayashi K. Watanabe D. Kobayashi K. Isa T. Viral vector-mediated selective and reversible blockade of the pathway for visual orienting in mice. Front. Neural Circuits 2013 7 162 10.3389/fncir.2013.00162 24130520 PMC3795302 source
This citation is attached to the mouse portion of the sentence, not the non-human-primate portion. The Methods identify rtTAV16 as the switch controlling the transgene construct, and the Results (Histological analysis; page unavailable) show doxycycline-dependent GFP expression in the mice. (LLM, conf=0.93)
- Not checked — no full text of the sourcecites [86] Tian X. Wang G. Xu Y. Wang P. Chen S. Yang H. Gao F. Xu A. Cao F. Jin X. Manyande A. Tian Y. An improved tet-on system for gene expression in neurons delivered by a single lentiviral vector. Hum. Gene Ther. 2009 20 2 113 123 10.1089/hum.2008.018 20377365 source
- Partly supportedcites [62] Manoussaka M.S. Berry N. Ferguson D. Stebbings R. Robinson M. Ham C. Page M. Li B. Das A.T. Berkhout B. Almond N. Cranage M.P. Conditionally-live attenuated SIV upregulates global T effector memory cell frequency under replication permissive conditions. Retrovirology 2013 10 1 59 10.1186/1742-4690-10-59 23738926 PMC3706341 sourceExperimental — accuracy not yet measured
The Methods (Animals and viruses; page unavailable) identify rtTA-V16 in the doxycycline-dependent SIV used to infect rhesus macaques. The Results (Differential localisation of SIV-rtTAΔnef and SIVΔnef in tissues; page unavailable) report viral transcripts in sampled tissues of doxycycline-treated macaques but not in those from which doxycycline was withdrawn. This supports V16-associated control of viral expression in non-human primates, but the paper does not demonstrate control of a separate transgene; the mice portion is attributed to other citations. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [87] Kinoshita M. Matsui R. Kato S. Hasegawa T. Kasahara H. Isa K. Watakabe A. Yamamori T. Nishimura Y. Alstermark B. Watanabe D. Kobayashi K. Isa T. Genetic dissection of the circuit for hand dexterity in primates. Nature 2012 487 7406 235 238 10.1038/nature11206 22722837 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
20 more claims · 2 with their cited sources checked
Create a free account to see all 58 claims and every source verdict.
- It may state two separate claims as one. 31
- The quote only partly states this claim. 1
- Probably not a substantial claim. 2
Citations
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943 · cited 2×
“1B), the 127-amino acid (127-aa) transcription activation domain (AD) of the herpes simplex virus VP16 protein was fused to the 207-aa TetR, which resulted in the tetracyclinecontrolled transcriptional activator (tTA) [11].”
BackgroundMethodChopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517 · cited 6×
“In Gram-negative bacteria, tetracycline resistance is mostly mediated by efflux of the drug by the membrane protein TetA [6, 7] and the TetA level is controlled by the tetracycline-responsive repressor protein TetR.”
BackgroundInfluentialTranscriptional Activation by Tetracyclines in Mammalian Cells
Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., & Bujard, H. (1995) · Science · doi:10.1126/science.7792603 · Cited by 2,488 · cited 2×
“Subsequent fusion of the VP16 activation domain resulted in a reverse-tTA (rtTA) that binds Ptet and activates transcription exclusively in the presence of dox [12].”
BackgroundUpdate on acquired tetracycline resistance genes
Roberts, M. C. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.02.034 · Cited by 1,010 · cited 1×
“nl tetracycline resistance: tetracycline efflux, ribosome protection and tetracycline modification [5].”
Urlinger, S., Baron, U., Thellmann, M., Hasan, M. T., Bujard, H., & Hillen, W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130192197 · Cited by 928 · cited 2×
“Furthermore, the rtTA coding sequence was optimized for human codon usage and putative toxic mRNA elements were removed: splice donor and acceptor sites, motifs for endonuclease cleavage sites and sequences inducing hairpin structures [15].”
BackgroundMethodRandomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD
Nutt, J. G., Burchiel, K. J., Comella, C. L., Jankovic, J., Lang, A. E., Laws, E. R., Lozano, A. M., Penn, R. D., Simpson, R. K., Stacy, M., et al. (2003) · Neurology · doi:10.1212/wnl.60.1.69 · Cited by 824 · cited 1×
“Because adverse effects of uncontrolled delivery of neurotrophic factors have been described [22-24], the ability to modulate transgene expression is crucial for these applications [25, 26].”
BackgroundMarks, W. J., Bartus, R. T., Siffert, J., Davis, C. S., Lozano, A., Boulis, N., Vitek, J., Stacy, M., Turner, D., Verhagen, L., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70254-4 · Cited by 684 · cited 1×
“Parkinson’s disease patients using an AAV vector [19].”
BackgroundMECHANISMS UNDERLYING EXPRESSION OF TN 10 ENCODED TETRACYCLINE RESISTANCE
Hillen, W., & Berens, C. (1994) · Annual Review of Microbiology · doi:10.1146/annurev.mi.48.100194.002021 · Cited by 511 · cited 1×
“The TetR proteins form dimers that recognize and bind the tetO elements, thus suppressing the activity of the PA and PR promoters and shutting off TetA and TetR production [9].”
BackgroundPathogenicity of Live, Attenuated SIV After Mucosal Infection of Neonatal Macaques
Baba, T. W., Jeong, Y. S., Pennick, D., Bronson, R., Greene, M. F., & Ruprecht, R. M. (1995) · Science · doi:10.1126/science.7892606 · Cited by 489 · cited 1×
“Evolution of the vaccine virus to a pathogenic variant did indeed cause disease in a minority of the vaccinated animals [46-49].”
BackgroundMoullan, N., Mouchiroud, L., Wang, X., Ryu, D., Williams, E. G., Mottis, A., Jovaisaite, V., Frochaux, M. V., Quiros, P. M., Deplancke, B., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.034 · Cited by 470 · cited 1×
“For example, rtTAs with an increased dox-sensitivity will require less dox, which will avoid cellular side effects due to the inhibitory effect of high tetracycline levels on mitochondrial translation [17].”
Background
Cited by
Yang, B., Li, M., Tang, W., Liu, W., Zhang, S., Chen, L., & Xia, J. (2018) · Nature Communications · doi:10.1038/s41467-018-03024-2 · Cited by 243
Comprehensive Overview of Bottom-Up Proteomics Using Mass Spectrometry
Jiang, Y., Rex, D. A. B., Schuster, D., Neely, B. A., Rosano, G. L., Volkmar, N., Momenzadeh, A., Peters-Clarke, T. M., Egbert, S. B., Kreimer, S., et al. (2024) · ACS Measurement Science Au · doi:10.1021/acsmeasuresciau.3c00068 · Cited by 190
Recording development with single cell dynamic lineage tracing
McKenna, A., & Gagnon, J. A. (2019) · Development · doi:10.1242/dev.169730 · Cited by 169
“Alternatively, environmental stimuli can be used to drive expression by coupling recorder components to drug- or heatinducible promoters (Das et al., 2016; Raj et al., 2018).”
BackgroundAn evolving view of copy number variants
Lauer, S. L., & Gresham, D. (2019) · Current Genetics · doi:10.1007/s00294-019-00980-0 · Cited by 151
Next-generation AAV vectors—Do not judge a virus (only) by its cover
Domenger, C., & Grimm, D. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz148 · Cited by 147
Metadata
- Authors
- T. Das, A., Tenenbaum, L., & Berkhout, B.
- Venue
- Current Gene Therapy
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2016-06-16
- Volume
- 16
- Issue
- 3
- Pages
- 156-167
- ISSN
- 1566-5232 (ISSN-L)
- PMC
- PMC5070417
- OpenAlex
- W2398436462
- Cited by
- 434
- References
- 89
- Citations by year
- 2026: 41 · 2025: 58 · 2024: 67 · 2023: 81 · 2022: 57 · 2021: 39 · 2020: 38 · 2019: 22 · 2018: 27 · 2017: 3
- FWCI
- 13.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc
- Locations
- Current Gene Therapy (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- SERVAL (Université de Lausanne) (publishedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- IRIS (submittedVersion)
- Funders
- Stichting voor de Technische Wetenschappen
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene Regulatory Network Analysis
- Keywords
- Tet-On system, Tet-off system, doxycycline-inducible expression, gene therapy vectors
- MeSH terms
- Bacterial Proteins, Carrier Proteins, Doxycycline, Escherichia coli, Gene Expression Regulation, Humans, Operon, Promoter Regions, Genetic, Tetracycline, Transfection, Vaccines, Attenuated, Genetic Therapy, HIV-1, AIDS Vaccines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tet-On Systems For Doxycycline-inducible Gene Expression. https://app.cochat.ai/papers/10.2174/1566523216666160524144041
- The paper
- T. Das, A., Tenenbaum, L., & Berkhout, B. (2016). Tet-On Systems For Doxycycline-inducible Gene Expression. Current Gene Therapy. https://doi.org/10.2174/1566523216666160524144041
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.